Impacts of baicalein analogs with modification of the 6th position of A ring on the activity toward NF-κB-, AP-1-, or CREB-mediated transcription

https://doi.org/10.1016/j.bmcl.2008.08.001Get rights and content

Abstract

The water extract of Scutellariae baicalensis Georgi (S. baicalensis) has potential anti-tumor and anti-inflammatory activities. A major flavonoid isolated from S. baicalensis, baicalein, was also found to have anti-tumor and anti-inflammatory activities. These biological activities could be due to their antioxidant action and/or effect on different signal transduction pathways. We investigated the effects of several baicalein analogs with a substitution of hydrogen of the hydroxyl group at the 6th position of A ring on three signal pathway mediated transcription (NF-κB, AP-1, and CREB) associated with inflammation and cancer growth. We found that the analogs with O-alkyl group of the different carbon chain length or O-benzyl activated NF-κB transcription without TNFα stimulation. Some of the analogs increased TNFα stimulated NF-κB transcription by two- to threefold. None of the analogs studied has major effect on AP-1 signal transduction with or without TPA stimulation. All of the analogs increased CREB transcription with forskolin stimulation up to twofold. However, they did not have a potent effect (less or about twofold activation) on intrinsic CREB signal transduction. The modification of baicalein at the 6th position of A ring was not correlated with change in these signal transduction pathways and cytotoxicity. Though, they are structural analogs, they are not functional analogs. Modification of baicalein at the 6th position could alter the specificity of action toward different cellular targets. Flavonoids could be chemophores in the development of drugs targeted at different signal transcriptional pathway.

Graphical abstract

SAR and effect on the NF-κB, AP-1, or CREB mediated transcription of baicalein analogs with modification of the 6th position of A ring.

  1. Download : Download full-size image

Section snippets

Acknowledgments

The authors thank Dr. T.J. Lee from Taiwan for providing oroxylin-A. We thank Dr. Elijah Paintsil and Scott Bussom for the critical reading of the manuscript. Dr. Sheng-Teng Huang was supported by Chang Gung Memorial Hospital Grant. This investigation was supported by Grant CA 063477 from the National Cancer Institute and Y.C. Cheng is a fellow of National Foundation for Cancer Research.

References and notes (18)

  • Y. Chen et al.

    Biochem. Pharmacol.

    (2000)
  • O. Hennebert et al.

    Steroid Biochem. Mol. Biol.

    (2008)
  • W.G. Deng et al.

    Blood

    (2004)
  • W. Gao et al.

    Bioorg. Med. Chem. Lett.

    (2007)
  • W. Gao et al.

    Bioorg. Med. Chem. Lett.

    (2008)
  • A.S. Kristof et al.

    J. Biol. Chem.

    (2001)
  • K.J. Woo et al.

    Int. Immunopharmacol.

    (2007)
  • S.J. Kim et al.

    Mol. Cell Biol.

    (2008)
  • S.H. Jeon et al.

    Mol. Cells

    (2007)
There are more references available in the full text version of this article.

Cited by (13)

  • Review of bioactivity and structure-activity relationship on baicalein (5,6,7-trihydroxyflavone) and wogonin (5,7-dihydroxy-8-methoxyflavone) derivatives: Structural modifications inspired from flavonoids in Scutellaria baicalensis

    2022, European Journal of Medicinal Chemistry
    Citation Excerpt :

    Most of the derivatives caused a 60% inhibition of DU145 cells only at a concentration of 100 mM or above. In 2008, Huang and co-workers [15] modified the 6th position of A ring of baicalein and investigated the activity of nuclear factor-kappa B (NF-κB), activator protein-1 (AP-1), or cyclic-AMP response element binding protein (CREB)-mediated transcription. The results showed that analogues with O-alkyl group of the different carbon chain length or O-benzyl activated NF-κB transcription without TNFα stimulation.

  • Modulation of diverse oncogenic signaling pathways by oroxylin A: An important strategy for both cancer prevention and treatment

    2022, Phytomedicine
    Citation Excerpt :

    OA has been proved to be a potential natural product against the treatment of nasopharyngeal cancer. For example, OA exhibited remarkable cytotoxicity against KB and multi drug resistant KB nasopharyngeal cancer cells (Huang et al., 2008). The most prevalent type of head and neck cancer is oral cancer, with oral squamous cell carcinoma (OSCC) being the most common single entity (Baek et al., 2016; Bordoloi et al., 2019; Girisa et al., 2021; Harsha et al., 2020; Jude et al., 2018; Rishabh et al., 2021; Singh et al., 2020).

  • Antifibrotic activities of Scutellariae Radix extracts and flavonoids: Comparative proteomics reveals distinct and shared mechanisms

    2022, Phytomedicine
    Citation Excerpt :

    Cai et al. (2017) reported kidney injury and fibrosis induced by oral administration of high doses of baicalin (400, 800 and 1600 mg/kg) for 8 days in rats. Hence, future R&D of baicalein-based antifibrotics may include the following key directions: first, determining the safe dosing range of baicalein for long-term use, as needed for prevention and treatment of many fibrotic disorders; second, examining its clinical efficacy and safety in fibrotic conditions, such as CKD; finally, unravelling the key structural basis underpinning activities and toxicity, and designing better baicalein derivatives with more robust antifibrotic activity and better safety profiles—this is plausible, given that baicalein derivatives have already achieved altered anti-P-glycoprotein activity, which is related to multiple drug resistance (Lee et al., 2004), altered regulation of NF-kB-, AP-1-, or CREB-mediated transcription (Huang et al., 2008) and more potent CDK1 inhibition and cancer repression (Ha et al., 2016). IN1130 is a positive control antifibrotic in this study.

  • Potential of baicalein in the prevention and treatment of cancer: A scientometric analyses based review

    2021, Journal of Functional Foods
    Citation Excerpt :

    S. baicalensis is widely distributed in several East Asian countries, including China, Korea, Mongolia, and Russia (Joshee, Patrick, Mentreddy, & Yadav, 2002; T. Zhao et al., 2019). This plant is also reported to comprise of other major flavonoids such as baicalin, wogonin, and oroxylin-A, that exerts wide range of pharmacological activities (S. T. Huang, Lee, Gullen, & Cheng, 2008). Due to its various biological activities, this plant is used in the Traditional Chinese Medicine (TCM), and are mentioned in various books of TCM such as Shennong Bencaojing and Bencao Gangmu (Compendium of Materia Medica), for the treatment of cold, hypertension, inflammation, insomnia, and lung and liver diseases (Weber, Wheat, & Currie, 2010; Gong et al., 2018; Zhu & Woerdenbag, 1995; Zhu & Woerdenbag, 1995).

View all citing articles on Scopus

Fellow of the National Foundation for Cancer Research.

View full text